300759 康龙化成
已收盘 07-26 15:00:00
资讯
新帖
简况
康龙化成(03759)：完成回购公司A股股份
智通财经网 · 07-26 19:18
康龙化成(03759)：完成回购公司A股股份
港股异动 | 康龙化成(03759)再涨超4% 公司需求逐步恢复 上半年新签订单稳健增长
智通财经 · 07-23
港股异动 | 康龙化成(03759)再涨超4% 公司需求逐步恢复 上半年新签订单稳健增长
建银国际：维持康龙化成“跑赢大市”评级 目标价降至12.5港元
智通财经 · 07-23
建银国际：维持康龙化成“跑赢大市”评级 目标价降至12.5港元
建银国际：维持康龙化成(03759)“跑赢大市”评级 目标价降至12.5港元
智通财经网 · 07-23
建银国际：维持康龙化成(03759)“跑赢大市”评级 目标价降至12.5港元
恒指全日收涨1.25% 医药外包概念普涨 康龙化成(03759)涨6.43%
金吾财讯 · 07-22
恒指全日收涨1.25% 医药外包概念普涨 康龙化成(03759)涨6.43%
康龙化成涨5.90%，民生证券二个月前给出“买入”评级
证券之星 · 07-22
康龙化成涨5.90%，民生证券二个月前给出“买入”评级
宽基ETF持续获资金青睐，沪深300成长ETF（562310）盘中溢价，康龙化成涨超5%丨ETF观察
21世纪经济报道 · 07-22
宽基ETF持续获资金青睐，沪深300成长ETF（562310）盘中溢价，康龙化成涨超5%丨ETF观察
医药外包概念普涨 康龙化成(03759)涨6.66% 东方证券料板块有望迎来边际改善
金吾财讯 · 07-22
医药外包概念普涨 康龙化成(03759)涨6.66% 东方证券料板块有望迎来边际改善
【AH互联】康龙化成(03759)涨超7% 料中期净利润同比增长至多45%
金吾财讯 · 07-22
【AH互联】康龙化成(03759)涨超7% 料中期净利润同比增长至多45%
康龙化成(03759.HK)升逾7% 料中期净利润增长最多45%
阿斯达克财经 · 07-22
康龙化成(03759.HK)升逾7% 料中期净利润增长最多45%
康龙化成早盘涨逾5% 公司预计中期纯利同比增长34%至45%
新浪港股 · 07-22
康龙化成早盘涨逾5% 公司预计中期纯利同比增长34%至45%
港股异动 | 康龙化成(03759)现涨超5% 二季度营收环比提高 公司预计中期纯利同比增长至多45%
智通财经 · 07-22
港股异动 | 康龙化成(03759)现涨超5% 二季度营收环比提高 公司预计中期纯利同比增长至多45%
康龙化成(03759)上涨5.05%，报9.15元/股
金融界 · 07-22
康龙化成(03759)上涨5.05%，报9.15元/股
康龙化成(03759)股价上升5.052%，现价港币$9.15
阿斯达克财经 · 07-22
康龙化成(03759)股价上升5.052%，现价港币$9.15
【公司盈喜】康龙化成(03759)料中期净溢利同比增长至多45%
金吾财讯 · 07-22
【公司盈喜】康龙化成(03759)料中期净溢利同比增长至多45%
《盈警》康龙化成(03759.HK)估计上半年扣除非经常性损益后净利润跌36%-41%
阿斯达克财经 · 07-21
《盈警》康龙化成(03759.HK)估计上半年扣除非经常性损益后净利润跌36%-41%
康龙化成(03759)预计上半年归母净利润10.55亿元-11.43亿元 同比增加34%-45%
智通财经 · 07-21
康龙化成(03759)预计上半年归母净利润10.55亿元-11.43亿元 同比增加34%-45%
康龙化成(300759.SZ)发预增，预计半年度净利润10.55亿元至11.43亿元，同比增长34%至45%
智通财经 · 07-21
康龙化成(300759.SZ)发预增，预计半年度净利润10.55亿元至11.43亿元，同比增长34%至45%
康龙化成：预计2024年1-6月归属净利润盈利10.55亿元至11.43亿元
证券之星 · 07-21
康龙化成：预计2024年1-6月归属净利润盈利10.55亿元至11.43亿元
暂无数据
公司概况
公司名称：
康龙化成(北京)新药技术股份有限公司
所属行业：
研究和试验发展
上市日期：
2019-01-28
主营业务：
康龙化成(北京)新药技术股份有限公司主营业务是从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要服务为实验室服务、CMC(小分子CDMO)服务、临床研究服务、大分子和细胞与基因治疗服务四大服务板块。
发行价格：
7.66
{"stockData":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":20.7,"timestamp":1721977425000,"preClose":20.84,"halted":0,"volume":14001350,"delay":0,"floatShares":1429000000,"shares":1787000000,"eps":0.83,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.14,"latestTime":"07-26 15:00:00","open":20.84,"high":21.03,"low":20.51,"amount":290000000,"amplitude":0.025,"askPrice":20.71,"askSize":138,"bidPrice":20.7,"bidSize":524,"shortable":0,"etf":0,"ttmEps":0.83,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"adjPreClose":20.84,"symbolType":"stock","openAndCloseTimeList":[[1721957400000,1721964600000],[1721970000000,1721977200000]],"highLimit":22.92,"lowLimit":18.76,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1787394297,"pbRate":2.96,"roa":"--","roe":"1.83%","epsLYR":0.9033,"committee":-0.253953,"marketValue":36999000000,"floatMarketCap":29572000000,"peRate":24.93976,"changeRate":-0.0067,"turnoverRate":0.0098,"status":1},"requestUrl":"/m/hq/s/300759/tweets","defaultTab":"tweets","newsList":[{"id":"2454131012","title":"康龙化成(03759)：完成回购公司A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2454131012","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454131012?lang=zh_cn&edition=full","pubTime":"2024-07-26 19:18","pubTimestamp":1721992697,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成 发布公告，2024年5月8日至2024年7月25日，公司通过在深圳证券交易所竞价回购合共960.83万股A股股份，占公司截至本公告日期已发行股本总额的约0.54%。回购股份的最高成交价为每股A股股份人民币22.27元，最低成交价为每股A股股份人民币17.89元。用于回购股份的资金总额为人民币2亿元。回购股份的实际实施并无偏离原先披露的回购计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1156299.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159982","300759","BK1141","BK1576","399300","BK0216","03759"],"gpt_icon":0},{"id":"2453377738","title":"港股异动 | 康龙化成(03759)再涨超4% 公司需求逐步恢复 上半年新签订单稳健增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2453377738","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453377738?lang=zh_cn&edition=full","pubTime":"2024-07-23 13:37","pubTimestamp":1721713046,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康龙化成(03759)再涨超4%，截至发稿，涨4.1%，报9.65港元，成交额4287.24万港元。消息面上，康龙化成近日发布盈喜，预计上半年营业收入54.71亿元-56.4亿元，同比下降0%-3%；归母净利润10.55亿元-11.43亿元，同比增加34%-45%。从上半年整体来看，预计公司营业收入同比阶段性略有下降；公司全球客户询单和访问同比有所回暖，新签订单金额同比增长超过15%。开源证券指出，公司需求逐步恢复，新签订单稳健增长。看好公司长期发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1154322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","300759","HSCEI","BK1576","BK1141","BK0216","YANG","03759"],"gpt_icon":1},{"id":"2453727593","title":"建银国际：维持康龙化成“跑赢大市”评级 目标价降至12.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453727593","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453727593?lang=zh_cn&edition=full","pubTime":"2024-07-23 10:16","pubTimestamp":1721700990,"startTime":"0","endTime":"0","summary":"建银国际发布研究报告称，维持康龙化成(03759)“跑赢大市”评级，目标价由13.8港元调低9.4%至12.5港元。虽然令人鼓舞的是公司业务营运因生物技术资金的增加按季回升，但该行对其复苏势头维 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20240723/c660056898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["300759"],"gpt_icon":0},{"id":"2453722267","title":"建银国际：维持康龙化成(03759)“跑赢大市”评级 目标价降至12.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453722267","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453722267?lang=zh_cn&edition=full","pubTime":"2024-07-23 10:00","pubTimestamp":1721700054,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，建银国际发布研究报告称，维持康龙化成“跑赢大市”评级，目标价由13.8港元调低9.4%至12.5港元。虽然令人鼓舞的是公司业务营运因生物技术资金的增加按季回升，但该行对其复苏势头维持审慎乐观看法。该行表示，将康龙化成2024-26年度CMC服务的销售预测下调19.5%，主要基于康龙化成的复苏速度慢于预期。此外，建银国际也调低康龙化成2024财年毛利率的预测11.8个百分点，但对该公司2024-26财年的毛利率预测上调11.8个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1154265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03759","300759"],"gpt_icon":0},{"id":"2453755627","title":"恒指全日收涨1.25% 医药外包概念普涨 康龙化成(03759)涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453755627","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453755627?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:23","pubTimestamp":1721636605,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数震荡走强，收市均涨超1%，截至收盘，恒指涨1.25%，国企指数涨1.44%，恒生科技指数涨2.10%。全球电力需求的强劲增长将持续到2025年，届时增长率仍将达到4%左右。医药外包概念普涨，康龙化成涨6.43%，维亚生物涨5.05%，药明生物涨3.88%，泰格医药涨3.85%。个股方面，美团涨幅3.23%。中信国际电讯 跌21.35%。中信国际电讯公布，预期截至6月30日止六个月于报告期间录得公司股东应占溢利约4.55亿港元，较截至2023年6月30日止六个月期间减少约37%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NTRiNjliMWYyMDZiNDZkN2Y3NDQyNTQ0NjcxNTMyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTRiNjliMWYyMDZiNDZkN2Y3NDQyNTQ0NjcxNTMyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940827","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1559","HK0000320223.HKD","LU0572940350.SGD","513600","03759","80992","81810","LU0791591158.USD","BK1583","LU0823426480.USD","300759","09939","XIACY","159938","LU1366334578.USD","LU0359201612.USD","HHImain","BK1574","BK1575","MHImain","03143","LU0067412154.USD","03968","HK0000320264.USD","LU0463099449.HKD","01810","00992","LU2778985437.USD","09961","YANG","LNVGY","LU0348816934.USD","LU0173614495.USD","MCHmain","LU0348735423.USD","LU0348805143.USD","LU0269904917.USD","03690","LU0231483743.USD","HSImain","HSI","LU0211977185.USD","BK1576","LU0348814723.USD","00017","LU0501845795.SGD","BK1502","01209","02833","SG9999002562.SGD","BK1610"],"gpt_icon":1},{"id":"2453375347","title":"康龙化成涨5.90%，民生证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2453375347","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453375347?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:04","pubTimestamp":1721635473,"startTime":"0","endTime":"0","summary":"今日康龙化成涨5.90%，收盘报21.19元。2024年4月26日，民生证券研究员王班,乔波耀发布了对康龙化成的研报《2024年一季报点评：Q1新签订单同比增长超20%，下游创新需求逐渐回暖》，该研报对康龙化成给出“买入”评级。此外，开源证券研究员余汝意,汪晋，中泰证券研究员祝嘉琦,崔少煜近期也对该股发布了研报，同样给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为民生证券的孙建。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200019386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","03759","161027"],"gpt_icon":0},{"id":"2453732560","title":"宽基ETF持续获资金青睐，沪深300成长ETF（562310）盘中溢价，康龙化成涨超5%丨ETF观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2453732560","media":"21世纪经济报道","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453732560?lang=zh_cn&edition=full","pubTime":"2024-07-22 15:01","pubTimestamp":1721631687,"startTime":"0","endTime":"0","summary":"相关ETF中， 沪深300 成长ETF现跌0.86%，成交额超500万，溢折率0.13%，盘中溢价交易明显。实际上，近期以沪深300ETF为代表的大盘宽基ETF持续获得资金青睐，盘中频频放量，且规模不断增长。Wind数据显示，截至7月19日，4只头部沪深300ETF合计规模超6500亿元，再创历史新高。沪深300成长ETF紧密跟踪沪深300成长指数，该指数以沪深300指数为样本空间，从中选取成长因子评分最高的100只股票作为样本股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221510249ede2a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221510249ede2a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300759","BK0216","03759","562310"],"gpt_icon":0},{"id":"2453891127","title":"医药外包概念普涨 康龙化成(03759)涨6.66% 东方证券料板块有望迎来边际改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2453891127","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453891127?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:40","pubTimestamp":1721616006,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念普涨，截至发稿，康龙化成 涨6.66%，维亚生物涨5.05%，泰格医药涨2.84%，药明生物涨2.77%。该行认为，CXO板块在经历业绩、估值双杀之后，有望迎来边际改善。方正证券认为，国内CXO企业正快步向新兴领域延伸，拓展新品类，并加快相关布局，希望承接全球相关产能需求，在未来五年的成长之路收获新增量。此外，头部企业康龙化成发布盈喜，截至2024年6月30日的半年度业绩预告。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/NjUzMWVjZjQ5MDRjNGY2OWIzOTk1NmJhNzg4ZTIwMmI4MTQyOTUwMDc1MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjUzMWVjZjQ5MDRjNGY2OWIzOTk1NmJhNzg4ZTIwMmI4MTQyOTUwMDc1MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940780","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","03958","BK0188","LU1688375341.USD","LU0043850808.USD","LU2039709279.SGD","03759","09939","LU0359202008.SGD","BK1589","SG9999002562.SGD","SG9999002463.SGD","BK1521","BK0216","01873","BK1610","LU0516422440.USD","600958","LU0348735423.USD","LU0456827905.SGD","LU0417516738.SGD","LU0856984785.SGD","LU0516423174.USD","LU0181495838.USD","LU0572944931.SGD","BK1576","BK1583","BK1141","BK1574","LU0051755006.USD","LU0327786744.USD","LU0823426480.USD","LU0320764599.SGD","LU0979878070.USD","LU0417516902.SGD","02269","159938","BK0276","300759","LU1794554557.SGD","BK0183","LU0819121731.USD","LU0348825331.USD","BK1147","LU0823426308.USD","LU1880383366.USD","LU0052750758.USD","BK1161","03347","LU0516423091.SGD"],"gpt_icon":0},{"id":"2453785022","title":"【AH互联】康龙化成(03759)涨超7% 料中期净利润同比增长至多45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453785022","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453785022?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:16","pubTimestamp":1721614611,"startTime":"0","endTime":"0","summary":"A股方面，康龙化成涨超5%，报21.04元人民币，成交额2.91亿元。归属于上市公司股东的净利润为10.55亿元人民币-11.43亿元人民币，同比增长约34%-45%。营业收入为54.71亿元人民币-56.4亿元人民币，同比下降0%-3%。公告指，业绩变动的原因为：1)2024年第一季度，公司营业收入同比下降1.95%。2)2024年第二季度，伴随着全球生物医药行业投融资的初步复苏，预计公司营业收入较2024年第一季度环比提高，较2023年第二季度同比实现小幅增长。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/MzBjNmFjYTg0ZGViYjVhMGFmODhkMDhhN2E5MzY4MTQyOTQ2MzQ2MjU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzBjNmFjYTg0ZGViYjVhMGFmODhkMDhhN2E5MzY4MTQyOTQ2MzQ2MjU=.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940776","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","300759"],"gpt_icon":0},{"id":"2453786624","title":"康龙化成(03759.HK)升逾7% 料中期净利润增长最多45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453786624","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453786624?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:14","pubTimestamp":1721614440,"startTime":"0","endTime":"0","summary":"康龙化成(03759.HK) 今日高开3.1%，最高见9.38元，一度升7.7%，见一个月新高。现报9.36元，升7.46%，成交299.25万股，涉资2,740.75万元。公司预期按中国会计准则，上半年归属股东净利润介乎10.55亿至11.43亿人民币，按年增长34%至45%。扣除非经常性损益后的归属股东净利润介乎4.45亿至4.83亿人民币，下降36%至41%。康龙化成(300759.SZ) 深圳上市A股现报20.84元人民币，升4.1%。(cy/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-07-19 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210817120930413_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210817120930413_s.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1365191/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03759","300759"],"gpt_icon":0},{"id":"2453478530","title":"康龙化成早盘涨逾5% 公司预计中期纯利同比增长34%至45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453478530","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453478530?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:57","pubTimestamp":1721613420,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 康龙化成（03759）早盘上涨4.94%，现报9.14港元，成交额1544.34万港元。\n 康龙化成发布业绩预告，预计2024年半年度归母净利10.55亿元-11.43亿元，同比增长34%-45%。公告称，第一季度，公司营业收入同比下降1.95%；第二季度，伴随着全球生物医药行业投融资的初步复苏，预计公司营业收入较2024年第一季度环比提高，较2023年第二季度同比实现小幅增长。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-22/doc-inceyhum1635127.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-22/doc-inceyhum1635127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03759","BK1141","300759","BK0216","BK1576"],"gpt_icon":0},{"id":"2453783360","title":"港股异动 | 康龙化成(03759)现涨超5% 二季度营收环比提高 公司预计中期纯利同比增长至多45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453783360","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453783360?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:48","pubTimestamp":1721612900,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康龙化成现涨超5%，截至发稿，涨4.48%，报9.1港元，成交额1153.5万港元。消息面上，康龙化成发布业绩预告，预计2024年半年度归母净利10.55亿元-11.43亿元，同比增长34%-45%。公告称，第一季度，公司营业收入同比下降1.95%；第二季度，伴随着全球生物医药行业投融资的初步复苏，预计公司营业收入较2024年第一季度环比提高，较2023年第二季度同比实现小幅增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","YANG","300759","HSTECH","HSCEI"],"gpt_icon":1},{"id":"2453788092","title":"康龙化成(03759)上涨5.05%，报9.15元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453788092","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453788092?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:40","pubTimestamp":1721612453,"startTime":"0","endTime":"0","summary":"7月22日，康龙化成(03759)盘中上涨5.05%，截至09:40，报9.15元/股，成交830.59万元。康龙化成是一家国际领先的生命科学研发服务企业，主要为小分子、大分子和细胞与基因治疗药物的研发提供全流程的研发生产服务。公司在中国、美国、英国开展运营，拥有14,000多名员工，服务的主要市场包括北美、欧洲、日本和中国。截至2024年一季报，康龙化成营业总收入26.71亿元、净利润2.31亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/22094041701312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300759","BK1141","BK1576","BK0216","03759"],"gpt_icon":0},{"id":"2453834477","title":"康龙化成(03759)股价上升5.052%，现价港币$9.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2453834477","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453834477?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:40","pubTimestamp":1721612400,"startTime":"0","endTime":"0","summary":"[上升股]康龙化成(03759) 股价在上午09:40比前收市价上升5.052%，现股价为港币$9.15。至目前为止，今日最高价为$9.15，而最低价为$8.85。总成交量为92.01万股，总成交金额为港币$829.674万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240722504/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["300759","BK1576","BK1141","BK0216","03759"],"gpt_icon":0},{"id":"2453120752","title":"【公司盈喜】康龙化成(03759)料中期净溢利同比增长至多45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453120752","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453120752?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:03","pubTimestamp":1721610207,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康龙化成 公布，截至2024年6月30日的半年度业绩预告。归属于上市公司股东的净利润为10.55亿元人民币-11.43亿元人民币，同比增长约34%-45%。业绩变动的原因为：1)2024年第一季度，公司营业收入同比下降1.95%。2)2024年第二季度，伴随着全球生物医药行业投融资的初步复苏，预计公司营业收入较2024年第一季度环比提高，较2023年第二季度同比实现小幅增长。","market":"sh","thumbnail":"https://static.szfiu.com/news/20200915/NjcwMDRkYTQ1ZjI5ZTlkNTkyYWIwMDM1OTZkMjUwMDIzNDA4Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NjcwMDRkYTQ1ZjI5ZTlkNTkyYWIwMDM1OTZkMjUwMDIzNDA4Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940757","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03759","300759","BK0216","BK1576"],"gpt_icon":0},{"id":"2453227791","title":"《盈警》康龙化成(03759.HK)估计上半年扣除非经常性损益后净利润跌36%-41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453227791","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453227791?lang=zh_cn&edition=full","pubTime":"2024-07-21 20:06","pubTimestamp":1721563560,"startTime":"0","endTime":"0","summary":"康龙化成发盈警，预计6月止六个月扣除非经常性损益后的归实股东净利润介乎4.45亿至4.83亿人民币，下降36%-41%；非《国际财务报告准则》净利润介乎6.71亿至7.18亿人民币，下降23%-28%。过往派息公布日期派息事项派息内容2024/04/25第一季业绩无派息2024/03/27末期业绩普通股息：人民币 0.2 2023/10/29第三季业绩无派息2023/08/27中期业绩无派息按中国会计准则，预计期间归实股东净利润介乎10.55亿至11.43亿人民币，按年增长34%-45%。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210817120929522_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210817120929522_s.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1365095/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["300759","03759"],"gpt_icon":0},{"id":"2453224574","title":"康龙化成(03759)预计上半年归母净利润10.55亿元-11.43亿元 同比增加34%-45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453224574","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453224574?lang=zh_cn&edition=full","pubTime":"2024-07-21 18:39","pubTimestamp":1721558359,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成 发布公告，预计公司截至2024年1月1日至2024年6月30日期间营业收入54.71亿元-56.4亿元，同比下降0%-3%;归属于上市公司股东的净利润10.55亿元-11.43亿元，同比增加34%-45%。公告称，从上半年整体来看，预计公司营业收入同比阶段性略有下降;公司全球客户询单和访问较2023年同期有所回暖，新签订单金额同比增长超过15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","300759"],"gpt_icon":0},{"id":"2453223250","title":"康龙化成(300759.SZ)发预增，预计半年度净利润10.55亿元至11.43亿元，同比增长34%至45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453223250","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453223250?lang=zh_cn&edition=full","pubTime":"2024-07-21 16:14","pubTimestamp":1721549687,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成 披露2024年半年度业绩预告，公司预计归属于上市公司股东的净利润10.55亿元至11.43亿元，同比增长34%至45%;归属于上市公司股东的扣除非经常性损益后的净利润4.45亿元至4.83亿元，同比下降36%至41%。公告显示，2024年第一季度，公司营业收入同比下降1.95%。2024年第二季度，伴随着全球生物医药行业投融资的初步复苏，预计公司营业收入较2024年第一季度环比提高，较2023年第二季度同比实现小幅增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300759","03759"],"gpt_icon":0},{"id":"2453235062","title":"康龙化成：预计2024年1-6月归属净利润盈利10.55亿元至11.43亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453235062","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453235062?lang=zh_cn&edition=full","pubTime":"2024-07-21 16:00","pubTimestamp":1721548844,"startTime":"0","endTime":"0","summary":"证券之星消息，康龙化成发布业绩预告，预计2024年1-6月归属净利润盈利10.55亿元至11.43亿元。公告中解释本次业绩变动的原因为：1、主营业务影响2024年第一季度,公司营业收入同比下降1.95%。康龙化成2024年一季报显示，公司主营收入26.71亿元，同比下降1.95%；归母净利润2.31亿元，同比下降33.8%；扣非净利润1.87亿元，同比下降46.01%；负债率47.09%，投资收益4656.92万元，财务费用6343.8万元，毛利率32.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072100006253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","03759"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-01-28","address":"北京市大兴区北京经济技术开发区泰河路6号1幢八层","stockEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":0.0838},{"period":"3month","weight":0.0917},{"period":"6month","weight":-0.0496},{"period":"1year","weight":-0.1911},{"period":"ytd","weight":-0.2782}],"companyName":"康龙化成(北京)新药技术股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"178739万元","compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0275},{"period":"3month","weight":-0.064},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1013},{"period":"ytd","weight":-0.0282}],"survey":" 康龙化成(北京)新药技术股份有限公司主营业务是从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要服务为实验室服务、CMC(小分子CDMO)服务、临床研究服务、大分子和细胞与基因治疗服务四大服务板块。","serverTime":1722086336072,"listedPrice":7.66,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,300759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}